EU Harmonization For Greek OTCs

10 March 1997

The Greek market for over-the-counter drugs is gray and flexible, withmany provisions of the July 1993 law harmonizing European Union and Greek legislation on the categorization of pharmaceuticals still not in force.

One of the main reasons for the problem lies in a dispute over translation and semantics; the law translates OTC as "non-prescribable," eg nonethical. Pharmacists prefer to use another translation: "drugs that do not have to be prescribed," eg semi-ethical. Categorizing more products as "non-ethical" would lead to an increase in self-medication which, while saving the state money, would squeeze pharmacists' margins.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight